관상동맥 질환용 약물 코팅 풍선 시장 기회 및 전략(-2035년)

Drug-coated balloons (DCBs) for coronary artery disease (CAD) refer to a category of interventional cardiovascular devices designed to treat narrowed or blocked coronary arteries through percutaneous coronary intervention (PCI). The primary purpose of DCBs in CAD treatment is to restore proper blood flow in diseased coronary arteries while minimizing the need for permanent implants like stents.

The drug-coated balloons for coronary artery disease market consists of sales, by entities (organizations, sole traders, or partnerships) that are used by interventional cardiologists and are deployed during PCI procedures commonly performed in hospitals, cardiac catheterization labs and, in some cases, ambulatory surgical centers. They are used at the time of balloon angioplasty, where the device is introduced via catheter, navigated to the lesion, inflated to dilate the artery and concurrently release the drug to prevent re-narrowing.

The global drug-coated balloons for coronary artery disease market was valued at $247.8 million in 2020 which grew till 2025 at a compound annual growth rate (CAGR) of more than 14.00%.

Higher Exposure To Smoking And Air Pollution

During the historic period, the drug-coated balloons for coronary artery disease market was driven by higher exposure to smoking and air pollution. Rising levels of fine particulate matter (PM2.5), emitted from vehicle exhaust, industrial activities, residential fuel combustion, and open burning, along with exposure to smoking, significantly elevate cardiovascular risk worldwide. Both PM2.5 particles and tobacco smoke contain harmful pollutants small enough to enter the bloodstream, triggering inflammation, endothelial dysfunction, and plaque instability, ultimately increasing the likelihood of developing coronary artery disease. For instance, in June 2024, the American Lung Association, a national organization dedicated to improving lung and cardiovascular health, released updated tobacco-use trend data highlighting significant increases in electronic cigarette usage. From 2014 to 2022, the proportion of adults who had ever used e-cigarettes rose by 56%, increasing from 12.6% to 19.6%, while adult current e-cigarette use grew by 62%, from 3.7% to 6.0%. Moreover, from 2011 to 2022, current use of e-cigarettes increased 667% among middle school students (from 0.6% to 4.6%) and 567% among high school students (from 1.5% to 10.0%). Additionally, in June 2024, the State of Global Air (SoGA), an independent initiative by the Health Effects Institute that provides global assessments of air pollution exposure and associated disease burden, published updated data on PM2.5 pollution and its health impacts for the year 2023, according to the report, PM2.5 exposure contributed to approximately 4.9 million deaths in 2023, making it one of the leading global risk factors for mortality. Therefore, the drug-coated balloons for coronary artery disease market was driven by higher exposure to smoking and air pollution.

Emergence Of Sirolimus-Eluting Drug-Coated Balloons As Advanced Solutions For Coronary Intervention

Major companies in the drug-coated balloons for coronary artery disease market are focusing on the development of sirolimus-eluting drug-coated balloons (DCBs) designed to provide enhanced vessel healing and broaden treatment options for both de novo lesions and in-stent restenosis. These advancements emphasize improved drug-release profiles, reduced inflammatory response and greater procedural flexibility, while offering clinicians implant-free solutions that align with evolving interventional strategies. For instance, in October 2025, Cordis, a US-based global cardiovascular device manufacturer, showcased new clinical data on its sirolimus-eluting balloon at the TCT 2025 conference, highlighting its performance in large, randomized studies evaluating outcomes in patients with both de novo coronary artery disease and in-stent restenosis. The reported results demonstrated non-inferiority to standard drug-eluting stent treatments, while also showing the potential to eliminate the need for permanent implants in a significant portion of patients. By utilizing advanced sirolimus-delivery technology and robust multi-trial clinical evidence, the company aims to support wider adoption of DCB solutions and to meet the evolving requirements of global coronary intervention markets.

The global drug-coated balloons for coronary artery disease market is highly concentrated, with large players operating in the market. The top 10 competitors in the market made up 81.98% of the total market in 2024.

Drug-Coated Balloons For Coronary Artery Disease Global Market Opportunities And Strategies To 2035 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global drug-coated balloons for coronary artery disease market as it emerges from the COVID-19 shut down.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market research findings.
• Benchmark performance against key competitors.
• Utilize the relationships between key data sets for superior strategizing.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Where is the largest and fastest-growing market for drug-coated balloons for coronary artery disease ? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The drug-coated balloons for coronary artery disease market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider drug-coated balloons for coronary artery disease market; and compares it with other markets.

The report covers the following chapters

• Introduction And Market Characteristics Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by type, by component and by application.
• Key Trends Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
• Growth Analysis And Strategic Analysis Framework Analysis on PESTEL, end use industries, market growth rate, global historic (2020-2025) and forecast (2025-2030, 2035F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods, forecast growth contributors and total addressable market (TAM).
• Global Market Size And Growth Global historic (2020-2025) and forecast (2025-2030, 2035F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
• Regional And Country Analysis Historic (2020-2025) and forecast (2025-2030, 2035F) market values and growth and market share comparison by region and country.
• Market Segmentation Contains the market values (2020-2025) (2025-2030, 2035F) and analysis for each segment by drug type and by end user in the market. Historic (2020-2025) and forecast (2025-2030) and (2020-2035) market values and growth and market share comparison by region market.
• Regional Market Size And Growth Regional market size (2025), historic (2020-2025) and forecast (2025-2030, 2035F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
• Competitive Landscape Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
• Other Major And Innovative Companies Details on the company profiles of other major and innovative companies in the market.
• Competitive Benchmarking Briefs on the financials comparison between major players in the market.
• Competitive Dashboard Briefs on competitive dashboard of major players.
• Key Mergers And Acquisitions Information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.
• Recent Developments Information on recent developments in the market covered in the report.
• Conclusions And Recommendations This section includes recommendations for drug-coated balloons for coronary artery disease providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
• Market Opportunities And Strategies Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
• Appendix This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

• 1) By Drug Type: Paclitaxel-Coated DCBs; Limus-Coated DCBs
• 2) By End-User: Hospitals; Cardiac Catheterization Labs; Ambulatory Surgical Centers; Other End-Users
• Companies Mentioned: B.Braun Melsungen AG; Boston Scientific Corporation; BIOTRONIK SE & Co. KG; Cordis Corporation (MedAlliance); Meril Life Sciences Pvt. Ltd.
• Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; UK; Italy; Spain; Russia
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time-series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; drug-coated balloons for coronary artery disease indicators comparison.
• Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1 Executive Summary

• 1.1 Drug-Coated Balloons For Coronary Artery Disease - Market Attractiveness And Macro Economic Landscape

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

• 6.1 General Market Definition
• 6.2 Summary
• 6.3 Drug-Coated Balloons For Coronary Artery Disease Market Definition And Segmentations
• 6.4 Market Segmentation By Drug Type
  • 6.4.1 Paclitaxel-Coated DCBs
  • 6.4.2 Limus-Coated DCBs
• 6.5 Market Segmentation By End User
  • 6.5.1 Hospitals
  • 6.5.2 Cardiac Catheterization Labs
  • 6.5.3 Ambulatory Surgical Centers
  • 6.5.4 Other End-Users

7 Major Market Trends

• 7.1 Emergence Of Sirolimus-Eluting Drug-Coated Balloons As Advanced Solutions For Coronary Intervention
• 7.2 Expansion Of Clinical Studies Evaluating Drug-Coated Balloons Against Standard Care In Coronary Interventions
• 7.3 Advancement of Next-Generation Coronary Drug-Coated Balloons (DCBs) for Broader Lesion Treatment

8 Pipeline Analysis Section Covering Clinical Studies For Drug-Coated Balloons For Coronary Artery Disease Including Their Clinical Phase And Launch Time For The Top 10 Companies

9 Pipeline Analysis Section Covering Clinical Studies For Paclitaxel-Coated DCBs And Limus-Coated DCBs

10 Drug-Coated Balloons For Coronary Artery Disease Market - Macro Economic Scenario

• 10.1 Impact of Interest Rate Fluctuations
• 10.2 Impact of Inflationary Pressures
• 10.3 Impact of Geopolitical Dynamics On Supply Chains
• 10.4 Impact of the COVID-19 Pandemic And Recovery
• 10.5 Strategic Insights And Future Outlook

11 Supply Chain Impact From Tariff War And Trade Protectionism

12 Global Drug-Coated Balloons For Coronary Artery Disease Growth Analysis And Strategic Analysis Framework

• 12.1 Global Drug-Coated Balloons For Coronary Artery Disease PESTEL Analysis
  • 12.1.1 Political
  • 12.1.2 Economic
  • 12.1.3 Social
  • 12.1.4 Technological
  • 12.1.5 Environmental
  • 12.1.6 Legal
• 12.2 Analysis Of End User (B2C)
  • 12.2.1 Hospitals
  • 12.2.2 Cardiac Catheterization Labs
  • 12.2.3 Ambulatory Surgical Centers
  • 12.2.4 Other End-Users
• 12.3 Global Drug-Coated Balloons For Coronary Artery Disease Market Growth Rate Analysis
• 12.4 Historic Market Growth, 2020 - 2025, Value ($ Million)
  • 12.4.1 Market Drivers 2020 - 2025
  • 12.4.2 Market Restraints 2020 - 2025
• 12.5 Forecast Market Growth, 2025 - 2030, 2035F Value ($ Million)
• 12.6 Forecast Growth Contributors/Factors
  • 12.6.1 Quantitative Growth Contributors
  • 12.6.2 Restraints
• 12.7 Total Addressable Market for the Drug-Coated Balloons For Coronary Artery Disease Market - Business to Customer (B2C)
  • 12.7.1 TAM Comparison Analysis

13 Global Drug-Coated Balloons For Coronary Artery Disease Market Segmentation

• 13.1 Global Drug-Coated Balloons For Coronary Artery Disease Market, Segmentation By Drug Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 13.2 Global Drug-Coated Balloons For Coronary Artery Disease Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 13.3 Global Drug-Coated Balloons For Coronary Artery Disease Market, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Volume (Number)
• 13.4 Global Drug-Coated Balloons For Coronary Artery Disease Market, Segmentation By Drug Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Volume (Number)

14 Global Estimated Number Of Clinical Trails For Paclitaxel-Coated DCBs And Limus-Coated DCBs For 2024

15 Drug-Coated Balloons For Coronary Artery Disease Market, Regional and Country Analysis

• 15.1 Global Drug-Coated Balloons For Coronary Artery Disease Market, By Region, Historic and Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 15.2 Global Drug-Coated Balloons For Coronary Artery Disease Market, By Country, Historic and Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

16 Asia-Pacific Market

• 16.1 Summary
• 16.2 Market Overview
  • 16.2.1 Region Information
  • 16.2.2 Market Information
  • 16.2.3 Background Information
  • 16.2.4 Government Initiatives
  • 16.2.5 Regulations
  • 16.2.6 Regulatory Bodies
  • 16.2.7 Major Associations
  • 16.2.8 Taxes Levied
  • 16.2.9 Corporate Tax Structure
  • 16.2.10 Investments
  • 16.2.11 Major Companies
• 16.3 Asia Pacific Drug-Coated Balloons For Coronary Artery Disease Market, Segmentation By Drug Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 16.4 Asia Pacific Drug-Coated Balloons For Coronary Artery Disease Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 16.5 Asia Pacific Drug-Coated Balloons For Coronary Artery Disease Market, Segmentation By Drug Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Volume (Number)
• 16.6 Asia-Pacific Drug-Coated Balloons For Coronary Artery Disease Market: Country Analysis
• 16.7 China Market
• 16.8 Summary
• 16.9 Market Overview
  • 16.9.1 Country Information
  • 16.9.2 Market Information
  • 16.9.3 Background Information
  • 16.9.4 Government Initiatives
  • 16.9.5 Regulations
  • 16.9.6 Regulatory Bodies
  • 16.9.7 Major Associations
  • 16.9.8 Taxes Levied
  • 16.9.9 Corporate Tax Structure
  • 16.9.10 Investments
  • 16.9.11 Major Companies
• 16.10 China Drug-Coated Balloons For Coronary Artery Disease Market, Segmentation By Drug Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 16.11 China Drug-Coated Balloons For Coronary Artery Disease Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 16.12 China Drug-Coated Balloons For Coronary Artery Disease Market, Segmentation By Drug Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Volume (Number)
• 16.13 India Market
• 16.14 India Drug-Coated Balloons For Coronary Artery Disease Market, Segmentation By Drug Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 16.15 India Drug-Coated Balloons For Coronary Artery Disease Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 16.16 Japan Market
• 16.17 Summary
• 16.18 Market Overview
  • 16.18.1 Country Information
  • 16.18.2 Market Information
  • 16.18.3 Background Information
  • 16.18.4 Government Initiatives
  • 16.18.5 Regulations
  • 16.18.6 Regulatory Bodies
  • 16.18.7 Major Associations
  • 16.18.8 Taxes Levied
  • 16.18.9 Corporate Tax Structure
  • 16.18.10 Investments
  • 16.18.11 Major Companies
• 16.19 Japan Drug-Coated Balloons For Coronary Artery Disease Market, Segmentation By Drug Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 16.20 Japan Drug-Coated Balloons For Coronary Artery Disease Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 16.21 Japan Drug-Coated Balloons For Coronary Artery Disease Market, Segmentation By Drug Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Volume (Number)
• 16.22 Australia Market
• 16.23 Australia Drug-Coated Balloons For Coronary Artery Disease Market, Segmentation By Drug Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 16.24 Australia Drug-Coated Balloons For Coronary Artery Disease Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 16.25 Indonesia Market
• 16.26 Indonesia Drug-Coated Balloons For Coronary Artery Disease Market, Segmentation By Drug Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 16.27 Indonesia Drug-Coated Balloons For Coronary Artery Disease Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 16.28 South Korea Market
• 16.29 Summary
• 16.30 Market Overview
  • 16.30.1 Country Information
  • 16.30.2 Market Information
  • 16.30.3 Background Information
  • 16.30.4 Government Initiatives
  • 16.30.5 Regulations
  • 16.30.6 Regulatory Bodies
  • 16.30.7 Major Associations
  • 16.30.8 Taxes Levied
  • 16.30.9 Corporate Tax Structure
  • 16.30.10 Investments
  • 16.30.11 Major Companies
• 16.31 South Korea Drug-Coated Balloons For Coronary Artery Disease Market, Segmentation By Drug Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 16.32 South Korea Drug-Coated Balloons For Coronary Artery Disease Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

17 Western Europe Market

• 17.1 Summary
• 17.2 Market Overview
  • 17.2.1 Region Information
  • 17.2.2 Market Information
  • 17.2.3 Background Information
  • 17.2.4 Government Initiatives
  • 17.2.5 Regulations
  • 17.2.6 Regulatory Bodies
  • 17.2.7 Major Associations
  • 17.2.8 Taxes Levied
  • 17.2.9 Corporate tax structure
  • 17.2.10 Investments
  • 17.2.11 Major Companies
• 17.3 Western Europe Drug-Coated Balloons For Coronary Artery Disease Market, Segmentation By Drug Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 17.4 Western Europe Drug-Coated Balloons For Coronary Artery Disease Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 17.5 Western Europe Drug-Coated Balloons For Coronary Artery Disease Market: Country Analysis
• 17.6 UK Market
• 17.7 UK Drug-Coated Balloons For Coronary Artery Disease Market, Segmentation By Drug Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 17.8 UK Drug-Coated Balloons For Coronary Artery Disease Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 17.9 Germany Market
• 17.10 Germany Drug-Coated Balloons For Coronary Artery Disease Market, Segmentation By Drug Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 17.11 Germany Drug-Coated Balloons For Coronary Artery Disease Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 17.12 France Market
• 17.13 France Drug-Coated Balloons For Coronary Artery Disease Market, Segmentation By Drug Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 17.14 France Drug-Coated Balloons For Coronary Artery Disease Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 17.15 Italy Market
• 17.16 Italy Drug-Coated Balloons For Coronary Artery Disease Market, Segmentation By Drug Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 17.17 Italy Drug-Coated Balloons For Coronary Artery Disease Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 17.18 Spain Market
• 17.19 Spain Drug-Coated Balloons For Coronary Artery Disease Market, Segmentation By Drug Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 17.20 Spain Drug-Coated Balloons For Coronary Artery Disease Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

18 Eastern Europe Market

• 18.1 Summary
• 18.2 Market Overview
  • 18.2.1 Region Information
  • 18.2.2 Market Information
  • 18.2.3 Background Information
  • 18.2.4 Government Initiatives
  • 18.2.5 Regulations
  • 18.2.6 Regulatory Bodies
  • 18.2.7 Major Associations
  • 18.2.8 Taxes Levied
  • 18.2.9 Corporate Tax Structure
  • 18.2.10 Major companies
• 18.3 Eastern Europe Drug-Coated Balloons For Coronary Artery Disease Market, Segmentation By Drug Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 18.4 Eastern Europe Drug-Coated Balloons For Coronary Artery Disease Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 18.5 Eastern Europe Drug-Coated Balloons For Coronary Artery Disease Market: Country Analysis
• 18.6 Russia Market
• 18.7 Russia Drug-Coated Balloons For Coronary Artery Disease Market, Segmentation By Drug Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 18.8 Russia Drug-Coated Balloons For Coronary Artery Disease Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

19 European Union (EU) Market

• 19.1 European Union (EU) Drug-Coated Balloons For Coronary Artery Disease Market, Segmentation By Drug Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 19.2 European Union (EU) Drug-Coated Balloons For Coronary Artery Disease Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 19.3 European Union (EU) Drug-Coated Balloons For Coronary Artery Disease Market, Segmentation By Drug Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Volume (Number)

20 North America Market

• 20.1 Summary
• 20.2 Market Overview
  • 20.2.1 Region Information
  • 20.2.2 Market Information
  • 20.2.3 Background Information
  • 20.2.4 Government Initiatives
  • 20.2.5 Regulations
  • 20.2.6 Regulatory Bodies
  • 20.2.7 Major Associations
  • 20.2.8 Taxes Levied
  • 20.2.9 Corporate Tax Structure
  • 20.2.10 Investments
  • 20.2.11 Major Companies
• 20.3 North America Drug-Coated Balloons For Coronary Artery Disease Market, Segmentation By Drug Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 20.4 North America Drug-Coated Balloons For Coronary Artery Disease Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 20.5 North America Drug-Coated Balloons For Coronary Artery Disease Market: Country Analysis
• 20.6 USA Market
• 20.7 Summary
• 20.8 Market Overview
  • 20.8.1 Country Information
  • 20.8.2 Market Information
  • 20.8.3 Background Information
  • 20.8.4 Government Initiatives
  • 20.8.5 Regulations
  • 20.8.6 Regulatory Bodies
  • 20.8.7 Major Associations
  • 20.8.8 Taxes Levied
  • 20.8.9 Corporate Tax Structure
  • 20.8.10 Investments
  • 20.8.11 Major Companies
• 20.9 USA Drug-Coated Balloons For Coronary Artery Disease Market, Segmentation By Drug Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 20.10 USA Drug-Coated Balloons For Coronary Artery Disease Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 20.11 USA Drug-Coated Balloons For Coronary Artery Disease Market, Segmentation By Drug Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Volume (Number)
• 20.12 Canada Market
• 20.13 Summary
• 20.14 Market Overview
  • 20.14.1 Country Information
  • 20.14.2 Market Information
  • 20.14.3 Background Information
  • 20.14.4 Government Initiatives
  • 20.14.5 Regulations
  • 20.14.6 Regulatory Bodies
  • 20.14.7 Major Associations
  • 20.14.8 Taxes Levied
  • 20.14.9 Corporate Tax Structure
  • 20.14.10 Major Companies
• 20.15 Canada Drug-Coated Balloons For Coronary Artery Disease Market, Segmentation By Drug Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 20.16 Canada Drug-Coated Balloons For Coronary Artery Disease Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 20.17 Canada Drug-Coated Balloons For Coronary Artery Disease Market, Segmentation By Drug Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Volume (Number)

21 South America Market

• 21.1 Summary
• 21.2 Market Overview
  • 21.2.1 Region Information
  • 21.2.2 Market Information
  • 21.2.3 Background Information
  • 21.2.4 Government Initiatives
  • 21.2.5 Regulations
  • 21.2.6 Regulatory Bodies
  • 21.2.7 Major Associations
  • 21.2.8 Taxes Levied
  • 21.2.9 Corporate Tax Structure
  • 21.2.10 Investments
  • 21.2.11 Major Companies
• 21.3 South America Drug-Coated Balloons For Coronary Artery Disease Market, Segmentation By Drug Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 21.4 South America Drug-Coated Balloons For Coronary Artery Disease Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 21.5 Brazil Market
• 21.6 Brazil Drug-Coated Balloons For Coronary Artery Disease Market, Segmentation By Drug Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 21.7 Brazil Drug-Coated Balloons For Coronary Artery Disease Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

22 Latin America Market

• 22.1 Latin America Drug-Coated Balloons For Coronary Artery Disease Market, Segmentation By Drug Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 22.2 Latin America Drug-Coated Balloons For Coronary Artery Disease Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 22.3 Latin America Drug-Coated Balloons For Coronary Artery Disease Market, Segmentation By Drug Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Volume (Number)

23 Middle East Market

• 23.1 Summary
• 23.2 Market Overview
  • 23.2.1 Region Information
  • 23.2.2 Market Information
  • 23.2.3 Background Information
  • 23.2.4 Government Initiatives
  • 23.2.5 Regulations
  • 23.2.6 Regulatory Bodies
  • 23.2.7 Major Associations
  • 23.2.8 Taxes Levied
  • 23.2.9 Corporate Tax Structure
  • 23.2.10 Major Companies
• 23.3 Middle East Drug-Coated Balloons For Coronary Artery Disease Market, Segmentation By Drug Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 23.4 Middle East Drug-Coated Balloons For Coronary Artery Disease Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

24 Africa Market

• 24.1 Summary
• 24.2 Market Overview
  • 24.2.1 Region Information
  • 24.2.2 Market Information
  • 24.2.3 Background Information
  • 24.2.4 Government Initiatives
  • 24.2.5 Regulations
  • 24.2.6 Regulatory Bodies
  • 24.2.7 Major Associations
  • 24.2.8 Taxes Levied
  • 24.2.9 Corporate Tax Structure
  • 24.2.10 Major Companies
• 24.3 Africa Drug-Coated Balloons For Coronary Artery Disease Market, Segmentation By Drug Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 24.4 Africa Drug-Coated Balloons For Coronary Artery Disease Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

25 Competitive Landscape And Company Profiles

• 25.1 Company Profiles
• 25.2 B. Braun Melsungen AG
  • 25.2.1 Company Overview
  • 25.2.2 Products And Services
  • 25.2.3 Business Strategy
  • 25.2.4 Financial Overview
• 25.3 Boston Scientific Corporation
  • 25.3.1 Company Overview
  • 25.3.2 Products And Services
  • 25.3.3 Business Strategy
  • 25.3.4 Financial Overview
• 25.4 BIOTRONIK SE & Co KG
  • 25.4.1 Company Overview
  • 25.4.2 Products And Services
  • 25.4.3 Business Strategy
  • 25.4.4 Financial Overview
• 25.5 Cordis Corporation (MedAlliance)
  • 25.5.1 Company Overview
  • 25.5.2 Products And Services
  • 25.5.3 Financial Overview
• 25.6 Meril Life Sciences Pvt. Ltd
  • 25.6.1 Company Overview
  • 25.6.2 Products And Services
  • 25.6.3 Financial Overview

26 Other Major And Innovative Companies

• 26.1 Acotec Scientific Holdings., Ltd.
  • 26.1.1 Company Overview
  • 26.1.2 Products And Services
• 26.2 Medtronic plc
  • 26.2.1 Company Overview
  • 26.2.2 Products And Services
• 26.3 Blue Sail Medical
  • 26.3.1 Company Overview
  • 26.3.2 Products And Services
• 26.4 OrbusNeich Medical Company Ltd.
  • 26.4.1 Company Overview
  • 26.4.2 Products And Services
• 26.5 MicroPort Scientific Corporation
  • 26.5.1 Company Overview
  • 26.5.2 Products And Services
• 26.6 Acotec Scientific Holdings., Ltd.
  • 26.6.1 Company Overview
  • 26.6.2 Products And Services
• 26.7 Medtronic plc
  • 26.7.1 Company Overview
  • 26.7.2 Products And Services
• 26.8 Blue Sail Medical
  • 26.8.1 Company Overview
  • 26.8.2 Products And Services
• 26.9 OrbusNeich Medical Company Ltd.
  • 26.9.1 Company Overview
  • 26.9.2 Products And Services
• 26.10 MicroPort Scientific Corporation
  • 26.10.1 Company Overview
  • 26.10.2 Products And Services

27 Competitive Benchmarking

28 Competitive Dashboard

29 Key Challenges in Drug-Coated Balloons For The Coronary Artery Disease Market

30 Key Mergers And Acquisitions

• 30.1 Teleflex Acquired Biotronik's Vascular Intervention business
• 30.2 Translumina Acquired Blue Medical Devices BV

31 Recent Developments In Drug-Coated Balloons For Coronary Artery Disease

• 31.1 Expansion Of Coronary Drug-Coated Balloon Use Through FDA-Approved Clinical Investigations

32 Future Outlook and Potential Analysis

• 32.1 Global Drug-Coated Balloons For Coronary Artery Disease Market In 2030 - Countries Offering Most New Opportunities
• 32.2 Global Drug-Coated Balloons For Coronary Artery Disease Market In 2030 - Segments Offering Most New Opportunities
• 32.3 Global Drug-Coated Balloons For Coronary Artery Disease Market In 2030 - Growth Strategies
  • 32.3.1 Market Trend Based Strategies
  • 32.3.2 Competitor Strategies

33 Appendix

• 33.1 Geographies Covered
• 33.2 Market Data Sources
• 33.3 Research Methodology
• 33.4 Currencies
• 33.5 The Business Research Company
• 33.6 Copyright and Disclaimer